Cost ‐effectiveness analysis of leadless cardiac resynchronization therapy

ConclusionWithin the model limitations, these findings support the use of WiSE-CRT in indicated patients from an economic standpoint. However, improving battery technology should be prioritized to maximize cost-effectiveness in times when health services are under significant financial pressures.

Source: Journal of Cardiovascular Electrophysiology - October 10, 2023 Category: Cardiology Authors: Nadeev Wijesuriya, Vishal Mehta, Felicity De Vere, Sandra Howell, Jonathan M. Behar, Andrew Shute, Michael Lee, Paolo Bosco, Steven A. Niederer, Christopher A. Rinaldi Tags: ORIGINAL ARTICLE Source Type: research